Medicine

OCT 23, 2026 · JOURNAL ARTICLE

Efficacy and safety of GLP-1 receptor agonists in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH)

Medicine

Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) are increasingly prevalent liver diseases c

OCT 23, 2026 · JOURNAL ARTICLE

Association between triglyceride-glucose index and total trabecular bone score in US adults

Medicine

This study examines the association between the triglyceride-glucose (TyG) index and trabecular bone score (TBS) among US adults. In this cross-sectional analysis of National Healt

OCT 23, 2026 · JOURNAL ARTICLE

Association between dampness syndrome severity and hyperuricemia after accounting for adiposity

Medicine

Dampness syndrome is a symptom-based traditional Chinese medicine pattern frequently observed in individuals with metabolic disorders. However, whether dampness syndrome severity p

OCT 16, 2026 · JOURNAL ARTICLE

Completed clinical trials of p53-targeted therapeutic strategies in cancer

Medicine

The tumor suppressor gene TP53 is one of the most frequently altered genes in human cancers and plays a central role in regulating cell cycle arrest, apoptosis, and genomic stabili

OCT 16, 2026 · JOURNAL ARTICLE

Influenza A (H1N1) virus infection complicated by checkpoint inhibitor pneumonitis

Medicine

Rationale: Checkpoint inhibitor pneumonitis (CIP) is a common, potentially severe adverse event in cancer patients receiving neoadjuvant immunotherapy, with glucocorticoids as the

OCT 9, 2026 · JOURNAL ARTICLE

Emergency treatment of acute massive hemorrhage during transbronchial lung biopsy outside operating room

Medicine

Rationale: Massive hemorrhage related to bronchoscopy procedures can occur suddenly, with rapid bleeding and difficulty in hemostasis, potentially leading to airway obstruction, as

OCT 9, 2026 · JOURNAL ARTICLE

Single-center experience with Romiplostim N01 for the management of severe persistent cancer therapy-induced thrombocytopenia in lung cancer

Medicine

Cancer therapy-induced thrombocytopenia (CTIT) is a common complication in patients with lung cancer undergoing treatment, leading to treatment delays and dose reductions. Romiplos

OCT 9, 2026 · JOURNAL ARTICLE

Analysis of a case of immune-related pancreatitis induced by anti-PD-1 antibody therapy for gastric cancer

Medicine

Background: Immune-related pancreatitis is a rare but clinically significant adverse event associated with immune checkpoint inhibitor therapy. Early recognition and appropriate ma